GLP-1 Chart

About This Site

This site is an independent education project. It shows the FDA labels of GLP-1 medicines next to each other, quoting each label's own words.

Last updated October 18, 2026. Labels read October 6, 2026.

On this page

Who runs it

It is run independently. It is not a clinic, a pharmacy, a drug maker or a store. It does not sell anything, and it does not take payment, ads or sponsorship from any drug maker.

Where the facts come from

Every medicine fact comes from the maker's FDA label, as posted on DailyMed by the National Library of Medicine. Each fact shows the label version and date. FDA approval records come from Drugs@FDA. Generic label counts come from openFDA, the FDA's public data service. One trial is named on the tirzepatide vs semaglutide page, by its DOI only. Background on GLP-1 itself comes from one review article, Drucker 2018 in Cell Metabolism, listed under Sources.

How the facts were checked

A script saved every label file from DailyMed on the day of the read. It then looked for each short quote on this site inside the right part of the right label file. A quote about an approved use, for example, has to be in section 1. If any quote is missing, the site does not build. On the last read, all 115 quotes were found.

The FDA application number on each label was also looked up in Drugs@FDA. Every label in the chart has an approval record there.

How the chart stays current

FDA labels change. Each month, we plan to read all of them again. A script compares the label versions with the ones in the chart. When a version changes, a person reads the new label before the chart changes. The date of the last read is on every page.

What it does not do

There is no ranking here, and no verdict on any medicine. You will not find amounts to take, product strengths, money figures or weight results. Side effects are left to the full label, which each row links to.

Nothing here is medical advice. Questions about your own care belong with your prescriber.

Who decides what goes on the site

The owner of this site decides what it covers. This site has no doctor or pharmacist on staff, and no medical reviewer. That is why it does not explain or judge the labels. It quotes them, with a link, and a script checks every quote.

Report an error

If something looks wrong, write to help@glp1comparisonchart.com with the page address and what you saw. Corrections are dated on the page that changed.

Sources

5 sources with read dates
  1. Ozempic label on DailyMed, Novo Nordisk, version 20 of 2026-06-01, read 2026-10-06
  2. Mounjaro label on DailyMed, Eli Lilly, version 40 of 2026-08-27, read 2026-10-06
  3. Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1, Drucker DJ, Cell Metabolism 2018, PMID 29617641, abstract read on PubMed 2026-10-06
  4. Drugs@FDA application records, US Food and Drug Administration, via the openFDA drugsfda API, read 2026-10-06
  5. openFDA drug label API, US Food and Drug Administration, read 2026-10-06